Sign in
4

Changes in Ownership

Arbutus Biopharma Corp Filed Acc 0001140361-17-014880

Options or other derivatives

  • Chief Technology Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Lutwyche Peter Chief Technology Officer 2017-03-24 Grant or award · Employee Stock Option (Right to Buy) +125,000 125,000 D
Loading xslF345X03/doc1.xml…